Skip to main content

Table 4 Descriptive analysis of the studied cases according to different parameters in HCM diagnosis (n = 12)

From: Could native T1 mapping replace late gadolinium enhancement in the assessment of myocardial fibrosis in patients with cardiomyopathy?

  Min. Max. Mean SD Median
RV EF 49.0 73.0 62.33 8.40 62.50
RV EDV 72.0 217.0 134.9 43.13 134.5
RV ESV 22.0 91.0 52.42 23.09 50.50
RV SV 49.0 126.0 82.17 24.39 79.50
RV EDVI 51.0 114.0 75.83 22.01 73.0
RV ESVI 15.0 48.0 29.42 12.07 24.50
RV SVI 25.0 62.0 45.58 11.0 45.0
LV EF 41.0 80.0 66.42 11.97 68.50
LV EDV 100.0 199.0 143.5 31.77 149.0
LV ESV 21.0 77.0 48.17 16.02 46.50
LV SV 41.0 131.0 98.0 27.78 103.0
LV EDVI 67.0 105.0 80.0 12.47 75.0
LV ESVI 14.0 57.0 27.92 11.57 25.0
LV SVI 33.0 78.0 53.17 11.88 50.50
LV MASS 224,49 94.5 213 88 499
  1. EDV(I) end-diastolic volume (indexed), EF ejection fraction, ESV(I) end-systolic volume (indexed), LV left ventricle, RV right ventricle, SV(I) stroke volume (indexed)